Prevalence of HIV P24 Antigen; A Sensitive Marker among Seronegative Antibody Blood Donors in Some Hospitals Within Kaduna Metropolis, Nigeria
DOI:
https://doi.org/10.47430/ujmr.2382.010Keywords:
Rapid Test Strip, HIV-1 infection, ELISA, Blood, Malaria Human Immunodeficiency Virus,, IgG antibody,Abstract
Detecting and monitoring HIV infection is crucial for effective disease management. The p24 antigen serves as an early viral marker in HIV diagnosis. Despite advancements in diagnosis and monitoring, there is a need for a comprehensive assessment of p24 antigen prevalence in HIV cases. Therefore, this study aims to ascertain the prevalence of p24 antigen among a diverse population of blood donors in Kaduna metropolis. The study recruited 261 blood donors aged between 18 and 55 from various blood bank units in the metropolis. Initial HIV status determination utilized the Immune-Chromatographic Determine® HIV rapid test kit, followed by re-screening with UnigoldRecombigen HIV 1 and 2, boasting 99.70% specificity and 100% sensitivity. HIGHTOP (HIV) ELISA test kit was employed to screen HIV antibodynegative blood donors for HIV p24 antigen. Additionally, demographic factors like gender, residency, age, and marital status were taken into account. Results indicated p24 antigen detection in 9 out of 261 blood samples, yielding a prevalence of 3.5%. Conversely, 252 samples tested negative for the antigen, resulting in a prevalence of 96.5%. The study's findings support the assertion that HIV p24 antigen serves as a sensitive marker, advocating for its integration into routine blood donor screening within Kaduna metropolis to enhance HIV infection detection rates.
Downloads
References
Abeni B., Frank-Peterside A.N., Agbagwa1 O. E., Adewuyi S.A., Cookey T.I., and Okonko, I.O. (2020). Seropositivity of Human Immunodeficiency Virus among Intending Blood Donors in Rivers State, Nigeria. Asian Journal of Research in Infectious Diseases. 4(3): 22-29. https://doi.org/10.9734/ajrid/2020/v4i330149
Adekunle, A., Oladele, O., and Ayodele, J. (2016). Legal Service Pro-bono: Charting a Path for Access to Justice in Nigeria. Readings in UN-Sustainable Development Goals and the Lagos Region. University of Lagos Press and Bookshop Ltd Works and Physical Planning Complex Unilag, P.O. Box 132, University of Lagos, Akoka, Yaba-Lagos, Nigeria. ISBN: 978-978-989-022-4.
Adoga, M. P., Gyar, S. D., Pechulano, S., Bashayi, O. D., Emiasegen, S. E., Zungwe, T., Iperepolu, O. H., Agupugo, C., & Agwale, S. M. (2010). Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests. The Journal of Infection in Developing Countries, 4(06), 397-400. https://doi.org/10.3855/jidc.591
Arthur, L.O., Peeters, M., Shaw, G.M. (1999). Origin of HIV-1 in the Chimpanzee Pan Troglodytes. Nature. 397, 436-441. https://doi.org/10.1038/17130.
Bani M., Giussani B. (2010). Gender differences in giving blood: A Review of Literature. Blood Transfusion. 2010; 8:278-87.
Carvalho, A.R.M., Pinto, C.M.A., and Baleanu, D. (2018). HIV/HCV Coinfection Model: A Fractional-Order Perspective for the Effect of the HIV Viral Load, Advances in Difference Equation 1 (2):1–22. https://doi.org/10.1186/s13662-017-1456.
Cochran, W.G. (1977). Sampling Techniques. 3rd Edition, John Wiley & Sons, New York.
Donegan E., Stuart M., Niland J.C., Sacks H.S, Azen S.P., Dietrich S.L., Faucett C., Fletcher M.A., Klienman S.H., and Operskalski E.A. (1990). Infection with Human Immununodeficiency Virus Type1 (HIV1) among Recipients of Antibody Positive Blood Donations. Annals of Internal Medicine. 113(10);733-739. https://doi.org/10.7326/0003-4819-113-10-733.
Ezejiofor, A.O. (2011). Patriarchy, Marriage and Rights of Widows in Nigeria. Unizik Journal of Arts and Humanities. 12 (1), 139-157
Gao P., Postiglione M.P., Krieger T.G., Hernandez L., Wang C., Han Z., Streicher C., Papusheva E., Insolera R., Chugh K., Kodish O., Huang K., Simons BD., Luo L., Hippenmeyer S., Shi S.H. (2014) Deterministic progenitor behaviour and unitary production of neurons in the neocortex. Cell. 159 (4); 775-88. https://doi.org/10.1016/j.cell.2014.10.027
Japhet M.O., Adewumi, O., Adesina, O., and Donbraye, E. (2016). High Prevalence of HIV P24 Antigen among HIV Antibody Negative Prospective Blood Donors in Ile-Ife, Nigeria. Journal of Immunoassay and Immunochemistry. https://doi.org/10.1080/15321819.2016.1174133
Japhet, M.O. (2020). Transfusion Transmissible Viral Pathogens among Blood Donors in Ibadan, Nigeria. Ife journal of Science.22 (2): 251-256. https://doi.org/10.4314/ijs.v22i2.22.
Kou, C., Yan, Y., and Liu, J. (2009). Stability Analysis for Fractional Differential Equations and their Applications in the Models of HIV-1 Infection, Computer Modelling Engineering science 39 (3) 301–317.
Kwaru A.H., Kuliya G.A., Jegede, F.E., Ofula, T., Imoru, M.O., Abubakar, A.G., Abubakar, A.A., and Dutse, A.I. (2014). Prevalence of Human Immunodeficiency Virus (HIV-1) P24 Antigen among HIV Antibody - Negative Blood Donors in Kano, Nigeria. JML
Lefrere, J., Dahourou, H., Dokekias, A.E., and Kouao, M.D. (2011). Estimate of the Residual Risk of Transfusion-Transmitted Human Immunodeficiency Virus Infection in Sub-Saharan Africa: A Multinational Collaborative Study. Transfusion. 51(3):486-492. PubMed|Google Scholar. https://doi.org/10.1111/j.1537-2995.2010.02886.
Moukoko, C.E., Sack, F.N., Mbangue, M.E., and Lehman, L.G. (2014). HIV, HBV HCV and T. Pallidium Infections among Blood Donors and Transfusion Related Complication among Recipients at the Laquitinie Hospital Douala, Cameroun. BMC Hematology 14(5). https://doi.org/10.1186/2052-1839-14-5
Ola, S.O., Jaiyesimi, A.E.A., and Olusanya, O.O. (2005). Co-infection of HIV and HBV among Nigerian Patients and Blood Donors at Sagamu. Nigeria Medical Journal. 46(3):64-67.
Osaro, E., Mohammed, N., Zama, I., Yakubu, A., Dorcas, I., Festus, A., Kwaifa, I., and Sani, I. (2014). Prevalence of P24 Antigen among a Cohort of HIV Antibody Negative Blood Donors in Sokoto, North Western Nigeria-The Question of Safety of Blood Transfusion in Nigeria. Pan African Medical Journal 2014, 18:174. https://doi.org/10.11604/pamj.2014.18.174.3449
Patel, P., Bennett, B., Sullivan, T., Parker, M.M., Heffelfinger, J.D., and Sullivan, P.S. (2012). Rapid HIV Screening: Missed Opportunities for HIV Diagnosis and Prevention. Journal of Clinical Virology.2012;54:42-7. https://doi.org/10.1016/j.jcv.2012.01.022.
Tigabu, A., Engda, T., and Mekonnen, F. (2019). Seroprevalence of Transfusion Transmisible Viral Infection (HIV, HBV, and HCV) among Voluntary Blood Donors at University of Gondar Comprehensive Specialised Hospital, Gondar; Northwest Ethiopia. BMC Infectious Disease.19(393);1-8. https://doi.org/10.1186/s12879-019-3950-2.
UNAIDS Report on the Global AIDS Epidemic (2020). Global Report 2020 UNAIDS Web Site. Available Online: https://www.unaids.org/en/resources/fact-sheet (accessed on 10 November 2020).
Weber E.U. (2006). Experience-Based and Description Based Perceptions of Long-Term Risk; Why Global Warming does not scare us (yet). Climatic change. 77, 103-120. https://doi.org/10.1007/s10584-006-9060-3
World Health Organisation, (2020). Available Online: https://www.afro.who.int/health-topics/hivaids (accessed on 10 November 2020).
Yooda, A.P., Saawadogo, S., Soubeiga, S.T., Yeboah, D.O., Nebie, K., Ouattara, A., Diarra, B., Simpore, A., Yonli, Y.D., Sawadodo, A.G., Drabo, B.E., Zalla, S., Siritie, A.P., Nana, R.S., Dahourou, H., and Simpore, J. (2019). Residual Risk of HIV, HCV, and HBV Transmission by Blood Transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso. Journal of Blood Medicine. 10:53-58. https://doi.org/10.2147/JBM.S189079.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 UMYU Journal of Microbiology Research (UJMR)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
